ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,403,752
-$61,261,681 QoQ
Shares Held
259,034
-64.9% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#37
of 503 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. AXSM ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in AXSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,403,752 | 259,034 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $124,665,433 | 737,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $67,134,445 | 367,578 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $54,045,250 | 445,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,662,330 | 447,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,598,240 | 48,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,076,600 | 60,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $47,181,750 | 525,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,765,000 | 730,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,097,000 | 515,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,050,350 | 365,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $22,714,250 | 325,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,935,805 | 444,417 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $64,764,000 | 1,050,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $82,143,450 | 1,065,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,693,000 | 150,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,014,254 | 783,662 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,903,500 | 650,000 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $14,250,000 | 200,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,456,000 | 200,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,000,550 | 85,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||